Lauren Santye, Assistant Editor

Analysts believe T-cell therapies must first show curative properties in blood cancer treatment to justify the price tag.

Analysts believe T-cell therapies must first show curative properties in blood cancer treatment to justify the cost.

Discovery holds promise for treatment of cirrhosis and liver damage related to hepatitis C.

HIV protein can impair neurocognitive function in nearly half of HIV-positive patients.

Phase 2 trial shows reduction in the cumulative total number of gadolinium-enhancing lesions in MS patients.

Diabetes and other conditions are also influenced by a person’s height.

Antiretroviral therapy taken early and frequently can limit the spread of HIV.

Poor decision making may cancel out advances in lower costs and increased research speed.

Ocrevus causes a significant reduction in disability progression in primary progressive multiple sclerosis.

Ocrevus targets a key contributor to myelin and axonal damage in primary progressive multiple sclerosis without harming other immune functions.

Gilotrif shows significant reduction in the risk of adenocarcinoma progression.

Inherited genetic variations leave acute lymphoblastic leukemia patients sensitive to drugs and at risk for toxicity.

New option approved for liver transplant patients and individuals with decompensated cirrhosis.

Scarring on the brain from MS can impact the ability to identify certain flavors.

Enhanced tumor analysis can help identify individual therapeutic cancer strategies.

New option approved for liver transplant patients and individuals with decompensated cirrhosis.

Many consumers are spending more than necessary as a result of choosing the wrong health insurance plan.

Issues with learning and paying attention associated with intensive chemotherapy for leukemia.

RNA-based drug infiltrates the virus to prevent HIV from replicating.

MS is difficult to diagnose because progression of the disease occurs at different rates.

Released prisoners given continued medication access are more likely to avoid re-arrests.

Numerous canine breeds develop cancers such as breast cancer and melanoma that have genetic similarities with the human equivalent disease.

Treatment can cause new blood vessel formation by activating signaling pathways.

Adenosine deaminase could help activate the immune system to rapidly fight and eliminate HIV.

Research could lead to the development of new cancer treatments.

Viral minigenome modifies the virus and and produces particles that are no longer harmful to humans.

Since the Affordable Care Act, $20.8 billion has been saved on prescription drugs at an average of $1945 per beneficiary.

Since the Affordable Care Act, $20.8 billion has been saved on prescription drugs at an average of $1945 per beneficiary.

Gilotrif shows significant reduction in the risk of adenocarcinoma progression.

Concerns raised over rise in opioid painkiller overdoses.